Correlation Between Visa and Farmaceutica
Can any of the company-specific risk be diversified away by investing in both Visa and Farmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Farmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and Farmaceutica R, you can compare the effects of market volatilities on Visa and Farmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Farmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Farmaceutica.
Diversification Opportunities for Visa and Farmaceutica
-0.84 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Visa and Farmaceutica is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Farmaceutica R in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Farmaceutica R and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Farmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Farmaceutica R has no effect on the direction of Visa i.e., Visa and Farmaceutica go up and down completely randomly.
Pair Corralation between Visa and Farmaceutica
Taking into account the 90-day investment horizon Visa Class A is expected to generate 0.51 times more return on investment than Farmaceutica. However, Visa Class A is 1.94 times less risky than Farmaceutica. It trades about 0.22 of its potential returns per unit of risk. Farmaceutica R is currently generating about -0.09 per unit of risk. If you would invest 27,442 in Visa Class A on September 28, 2024 and sell it today you would earn a total of 4,465 from holding Visa Class A or generate 16.27% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 98.41% |
Values | Daily Returns |
Visa Class A vs. Farmaceutica R
Performance |
Timeline |
Visa Class A |
Farmaceutica R |
Visa and Farmaceutica Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Visa and Farmaceutica
The main advantage of trading using opposite Visa and Farmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Farmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Farmaceutica will offset losses from the drop in Farmaceutica's long position.Visa vs. American Express | Visa vs. Upstart Holdings | Visa vs. Capital One Financial | Visa vs. Ally Financial |
Farmaceutica vs. Oil Terminal C | Farmaceutica vs. Antibiotice Ia | Farmaceutica vs. Aages SA | Farmaceutica vs. Alumil Rom Industry |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
CEOs Directory Screen CEOs from public companies around the world | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |